Examkin

Soru

Zorluk: ZorDiagnostic and Screening Test Performance

Investigators at a tropical medicine research institute are validating a new rapid antigen test for a mosquito-borne virus. In the initial case-control validation study, the cohort is constructed with an equal number of confirmed infected patients and healthy volunteers (a forced disease prevalence of 50%50\%). Within this specific study population, the test demonstrates a positive predictive value of 90%90\% and a negative predictive value of 90%90\%.

The test is subsequently deployed to a rural clinic for screening, where the estimated prevalence of the virus among presenting patients is 10%10\%.

Assuming the inherent performance characteristics of the test remain unchanged, what is the expected positive predictive value of the test in this rural clinic setting?

  1. A
    10%10\%
  2. 50%50\%Cevap
  3. C
    81%81\%
  4. D
    90%90\%
  5. E
    99%99\%

Cevap

The positive predictive value drops to 50%50\% in the new setting.
The correct answer accurately recalculates the positive predictive value (PPV) based on the shift in disease prevalence. In the initial study with a 50%50\% prevalence, the test's PPV (90%90\%) and NPV (90%90\%) indicate that the intrinsic sensitivity and specificity of the test are both 90%90\%. When this test is moved to a setting with a 10%10\% prevalence, a standard 2×22 \times 2 table analysis for 10001000 patients yields 100100 diseased and 900900 healthy individuals. Applying the 90%90\% sensitivity results in 9090 True Positives. Applying the 90%90\% specificity results in an False Positive rate of 10%10\%, which yields 9090 False Positives (900×0.10900 \times 0.10). The new PPV is the ratio of True Positives to all positive test results: 90/(90+90)=50%90 / (90 + 90) = 50\%.

Adım Adım Çözüm

1
Determine the intrinsic characteristics (sensitivity and specificity) of the test using the validation cohort data.
Sensitivity is 90%90\% and Specificity is 90%90\%.
In a population with a 50%50\% prevalence, there is an equal number of diseased and healthy individuals. A positive predictive value (PPV) of 90%90\% and negative predictive value (NPV) of 90%90\% mathematically mandate that the underlying true positive rate (sensitivity) and true negative rate (specificity) must both be 90%90\%.
2
Create a hypothetical population based on the new rural clinic prevalence of 10%10\%.
In a hypothetical cohort of 10001000 patients, 100100 have the virus and 900900 do not.
Setting up a standard 2×22 \times 2 matrix with a hypothetical population simplifies the calculation of true and false positives.
3
Calculate the absolute number of True Positives (TP) and False Positives (FP) in this new population.
TP=100×0.90=90TP = 100 \times 0.90 = 90. FP=900×(1−0.90)=90FP = 900 \times (1 - 0.90) = 90.
True positives depend on the test's sensitivity applied to the infected population. False positives depend on the false positive rate (1−specificity1 - \text{specificity}) applied to the healthy population.
4
Calculate the new Positive Predictive Value (PPV) using the TP and FP values.
PPV=TPTP+FP=9090+90=90180=50%PPV = \frac{TP}{TP + FP} = \frac{90}{90 + 90} = \frac{90}{180} = 50\%.
Positive predictive value is defined as the proportion of all positive test results that are true positives.

Anahtar Kavram

While sensitivity and specificity are intrinsic to a diagnostic test, Positive Predictive Value (PPV) and Negative Predictive Value (NPV) are highly dependent on the prevalence of the disease in the population being tested. As prevalence decreases, PPV decreases and NPV increases.
Bu soruyu puanla

Konular

Diagnostic and Screening Test Performance

Bu konudan daha fazla soru